Xiuchao P. Wang

No. 5 Kaituo Street
Haidian, 100085, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Retraction Note: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.

Journal: Signal transduction and targeted therapy
Published: January 03, 2026

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma.

Journal: Cancer biology & medicine
Published: October 17, 2025

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K/AKT/HIF-1α pathway.

Journal: Cancer biology & medicine
Published: September 30, 2025

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters.

Journal: Cancer biology & medicine
Published: September 27, 2025

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Senescent Cancer-Associated Fibroblasts Drive Early-Stage Lymph Node Metastasis in Pancreatic Cancer through Lactate-Mediated Metabolic-Epigenetic Rewiring.

Journal: Cancer discovery
Published: September 18, 2025

Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer.

Targeting the SIN1 mediated TTK/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer.

Journal: Cancer letters
Published: September 16, 2025

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

NALIRIFOX versus gemcitabine plus nab-paclitaxel in Chinese patients with advanced pancreatic adenocarcinoma: a randomized, open-label phase II trial.

Journal: Nature communications
Published: August 28, 2025

HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma.

HCAR2 Orchestrates an Immunosuppressive Niche and Determines Checkpoint Inhibitor Responsiveness in Esophageal Squamous Cell Carcinoma.

Journal: Biological procedures online
Published: May 11, 2025

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Trogocytosis-orchestrated CLDN18.2-"dressed" CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade.

Journal: Gut
Published: May 05, 2025

Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.

Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 25, 2025

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer.

Journal: Signal transduction and targeted therapy
Published: April 16, 2025

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Development and Prospective Validation of a Cell-free DNA-Based Model for the Early Detection of Pancreatic Cancer.

Journal: Cancer discovery
Published: February 26, 2025
Showing 1-12 of 82

Last Updated: 09/26/2026